We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-7.25%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
–
AUM
$171M
AUM Growth
+$4.01M
Cap. Flow
+$16.8M
Cap. Flow %
9.85%
Top 10 Hldgs %
55.16%
Holding
228
New
107
Increased
39
Reduced
38
Closed
10

Top Buys

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$3.44M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$3.38M
3
IYR icon
iShares US Real Estate ETF
IYR
+$1.4M
4
FCAL icon
First Trust California Municipal High income ETF
FCAL
+$841K
5
EUSA icon
iShares MSCI USA Equal Weighted ETF
EUSA
+$602K

Top Sells

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.53M
3
BNDX icon
Vanguard Total International Bond ETF
BNDX
+$1.38M
4
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$1.25M
5
SPIP icon
State Street SPDR Portfolio TIPS ETF
SPIP
+$548K

Sector Composition

Rank Sector Weight
1 Technology 4.05%
2 Communication Services 3.01%
3 Financials 1.84%
4 Healthcare 1.26%
5 Consumer Staples 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XERS icon
176
Xeris Biopharma Holdings
XERS
$1.39B
$26K 0.02%
+10,000
New +$24.4K
IVR icon
177
Invesco Mortgage Capital
IVR
$756M
$25K 0.01%
+1,098
New +$27K
VCLT icon
178
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$23K 0.01%
245
+54
+28% +$5.25K
SRNE
179
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$23K 0.01%
+10,000
New +$31.2K
EPZM
180
DELISTED
Epizyme, Inc
EPZM
$23K 0.01%
+20,000
New +$32.6K
RPG icon
181
Invesco S&P 500 Pure Growth ETF
RPG
$2.03B
$22K 0.01%
600
– –
ADAP
182
DELISTED
Adaptimmune Therapeutics
ADAP
$21K 0.01%
+10,000
New +$27K
ASMB icon
183
Assembly Biosciences
ASMB
$492M
$21K 0.01%
+833
New +$17.9K
IWR icon
184
iShares Russell Mid-Cap ETF
IWR
$56.2B
$21K 0.01%
268
– –
VSS icon
185
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
$21K 0.01%
173
+170
+5,667% +$21.3K
ADVM
186
DELISTED
Adverum Biotechnologies
ADVM
$20K 0.01%
+1,500
New +$21.9K
WVE icon
187
Wave Life Sciences
WVE
$1.08B
$20K 0.01%
+10,000
New +$24.5K
CLVS
188
DELISTED
Clovis Oncology, Inc.
CLVS
$20K 0.01%
+10,000
New +$19.6K
IEF icon
189
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$19K 0.01%
+176
New +$19.5K
ICVT icon
190
iShares Convertible Bond ETF
ICVT
$7.31B
$17K 0.01%
+204
New +$16.9K
VB icon
191
Vanguard Morningstar Small-Cap ETF
VB
$80.4B
$15K 0.01%
70
– –
VTV icon
192
Vanguard Morningstar Value ETF
VTV
$188B
$15K 0.01%
100
– –
AXDX
193
DELISTED
Accelerate Diagnostics
AXDX
$14K 0.01%
+1,000
New +$28.5K
IRON icon
194
Disc Medicine
IRON
$2.92B
$14K 0.01%
+333
New +$17.5K
REZ icon
195
iShares Residential and Multisector Real Estate ETF
REZ
$876M
$14K 0.01%
146
– –
IWN icon
196
iShares Russell 2000 Value ETF
IWN
$14.5B
$13K 0.01%
80
+60
+300% +$9.57K
TECX
197
Tectonic Therapeutic
TECX
$527M
$13K 0.01%
+833
New +$17.2K
HYMB icon
198
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.17B
$12K 0.01%
434
– –
SLDB icon
199
Solid Biosciences
SLDB
$784M
$12K 0.01%
+667
New +$11.8K
VO icon
200
Vanguard Morningstar Mid-Cap ETF
VO
$107B
$10K 0.01%
164
– –
6 7
8
9 10

Similar funds

PWM
Platform Wealth Management Holladay, Utah $376M AUM
RC
Rovin Capital Mesa, Arizona $377M AUM 13.67% 1-Year Est. Return
EP
EnCap Partners Houston, Texas $383M AUM 10.44% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
DP
Divergent Planning Bethesda, Maryland $392M AUM 13.55% 1-Year Est. Return

Running Point Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Running Point Capital Advisors held 228 positions worth $171M, up 2.4% from $167M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Running Point Capital Advisors deployed $16.8M of net new capital in Q1 2022, opening 107 new positions and adding to 39 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 11,412 shares worth $558K.

By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 5.6% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $2.01M trimmed.

  • Running Point Capital Advisors's largest Q1 2022 buy was JPMorgan International Bond Opportunities ETF: 11,412 shares worth $558K.
  • Running Point Capital Advisors added most to iShares Core MSCI Emerging Markets ETF in Q1 2022, an estimated $3.44M increase.
  • Running Point Capital Advisors's biggest Q1 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $2.01M.
  • Running Point Capital Advisors fully exited Starbucks in Q1 2022, selling an estimated $279K.
  • Running Point Capital Advisors's ten largest holdings make up 55% of its $171M portfolio in Q1 2022.
  • Running Point Capital Advisors opened 107 new positions and closed 10 in Q1 2022.
  • Running Point Capital Advisors's portfolio value rose 2.4% quarter-over-quarter to $171M.

Based on Running Point Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.